Snapshot from May 30, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Organon & Co.

Tracked across 6 events · 52 articles · First seen May 23, 2025 · Last active May 25, 2026

Sentiment
-68
Attention
4
Events
6
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
4 -70
Business
Impact: Organon & Co. is the primary defendant in the class action lawsuit, accused of making misleading statements regarding its capital allocation priorities and dividend payout, which led to a significant stock price drop.
May 23, 2025 · 7 articles
2 -70
Business
Impact: Organon & Co. is facing a class action lawsuit for allegedly making false and misleading statements regarding its capital allocation and debt reduction strategy, which led to a significant drop in its stock price.
May 29, 2025 · 6 articles
4 -80
Business
Impact: Organon & Co. is facing a federal securities class action lawsuit for allegedly making false and misleading statements regarding its capital allocation strategy and dividend priorities, which led to a significant stock price decline.
May 23, 2025 · 6 articles
4 -70
Business
Impact: Organon & Co. is being sued for securities fraud after allegedly misleading investors about its capital allocation priorities, leading to a significant dividend cut and a 27% stock price decline. The company's actions have negatively impacted its stock price and reputation.
May 31, 2025 · 21 articles
3 -70
Business
Impact: Organon & Co. is facing a class action lawsuit for allegedly misleading investors about its capital allocation strategy, particularly regarding dividend payments and debt reduction following its acquisition of Dermavant. This led to a significant drop in its stock price.
May 30, 2025 · 6 articles
2 -50
Business
Impact: Organon & Co. is facing a class action lawsuit for allegedly making false and misleading statements regarding its capital allocation and debt reduction strategy, which led to a 70% decrease in its quarterly dividend and investor damages.
May 29, 2025 · 6 articles
Roivant Sciences acquirer Organon & Co. Organon & Co. acquired Roivant Sciences for $1.2 billion in October 2024, a tran
Roivant Sciences target Organon & Co. Roivant Sciences was acquired by Organon & Co. for $1.2 billion in October 2024.
NEWSDESK
Track Organon & Co. live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.